- ISPOR 2020
- ISPOR Asia Pacific 2020
- ISPOR Europe 2020
- ISPOR-FDA Summit 2020
- ISPOR 2021
- ISPOR Europe 2019
- ISPOR Summit 2019
- ISPOR Latin America Summit 2019
- ISPOR Latin America 2019
- ISPOR 2019
- ISPOR Warsaw 2019
- ISPOR Europe 2018
- ISPOR Summit 2018
- ISPOR Dubai 2018
- ISPOR Asia Pacific 2018
- ISPOR 2018
- ISPOR Europe 2017
- ISPOR Latin America 2017
- ISPOR Asia Pacific 2016
- Abstract Information
- Submit Abstract
- Exhibits & Sponsorships
- Awards & Grants
- Recent Conferences
- Upcoming Conferences
Education & Training
- Value Assessment in the Age of COVID-19: Meeting the Challenges
- French Administrative Health Care Database (SNDS): Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU
- Open Source Models in HEOR: Benefits, Challenges, and ISPOR Members’ Perceptions
- Biosimilars: Unleashing The Potential For Improved Patient Access And Cost Savings In The United States
- Methods Maze: Pointers for Selecting Survival Extrapolation Models for Cancer Immunotherapy
- ONE HEALTH PERSPECTIVES ON HEOR
- Valuing Future Alzheimer’s Disease Medicines: Extending the Traditional Paradigm
- Health Technology Assessment Training
- Short Courses
This module is an introduction to the role of cost-of-illness (COI)/cost-estimation (CE) in medical decision making from multiple perspectives. It will describe uses of COI/CE analysis for resource allocation, policy-making and baseline research/benchmarking, different approaches to computational methods, cost components and determination of cost drivers.
By the end of the Cost-of-Illness/Cost-Estimation (COI/CE) module, you will be able to:
- State the role of cost-of-illness (COI)/cost-estimation in medical decision making.
- Define the components of COI analysis.
- Understand the computations involved in COI analysis.
- Understand the concerns in attribution of cost components to a particular illness or time period.